Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes
- PMID: 75547
- PMCID: PMC411265
- DOI: 10.1073/pnas.75.1.441
Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes
Abstract
During each transplantation passage of a line of mouse myeloma tumor MOPC-315 through syngeneic (BALB/c) hosts, the tumor cells lose reactivity with cytotoxic thymus-derived lymphocytes directed against products of the BALB/c major histocompatibility complex (H-2d) and regain reactivity on transfer to fresh hosts. In contrast to this cyclical change, the tumor cells remain uniformly reactive with anti-H-2d alloantisera throughout the transplantation cycle.
Similar articles
-
Loss of reactivity of a BALB/c myeoloma tumor with allogeneic and syngeneic cytotoxic T lymphocytes.Eur J Immunol. 1978 Sep;8(9):640-5. doi: 10.1002/eji.1830080907. Eur J Immunol. 1978. PMID: 309400
-
Loss of reactivity of a myeloma tumor with H-2 compatible thymus-derived lymphocytes.Cell Immunol. 1979 Sep 1;46(2):337-47. doi: 10.1016/0008-8749(79)90421-0. Cell Immunol. 1979. PMID: 226273 No abstract available.
-
Periodic fluctuations in resistance of a myeloma tumor (MOPC-315-el) to cytotoxic T lymphocytes.Cell Immunol. 1981 Jul 15;62(1):119-31. doi: 10.1016/0008-8749(81)90305-1. Cell Immunol. 1981. PMID: 6973405 No abstract available.
-
Suppressor cells in neoplastic disease.J Natl Cancer Inst. 1978 Jul;61(1):5-11. doi: 10.1093/jnci/61.1.5. J Natl Cancer Inst. 1978. PMID: 353295 Review. No abstract available.
-
Occurrence and potential significance of increased numbers of T cells with Fc receptors in myeloma.Immunol Rev. 1981;56:115-39. doi: 10.1111/j.1600-065x.1981.tb01049.x. Immunol Rev. 1981. PMID: 7016731 Review. No abstract available.
Cited by
-
Herman N. Eisen: Mentor to many.Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1650-1. doi: 10.1073/pnas.1500050112. Epub 2015 Jan 23. Proc Natl Acad Sci U S A. 2015. PMID: 25617368 Free PMC article. No abstract available.
-
Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes.Proc Natl Acad Sci U S A. 1980 Oct;77(10):6105-8. doi: 10.1073/pnas.77.10.6105. Proc Natl Acad Sci U S A. 1980. PMID: 6255476 Free PMC article.
-
Elicitation of anti-vesicular stomatitis virus cytotoxic T lymphocytes by using purified viral and cellular antigens incorporated into phospholipid vesicles.Infect Immun. 1981 May;32(2):513-7. doi: 10.1128/iai.32.2.513-517.1981. Infect Immun. 1981. PMID: 6265359 Free PMC article.
-
Variation of expression of histocompatibility antigens on tumor cells: absence of H-2Kk-gene products from a gross-virus-induced leukemia in BALB.K.Immunogenetics. 1981;14(3-4):323-39. doi: 10.1007/BF00342201. Immunogenetics. 1981. PMID: 7333657
-
Dissociation of H-2 recognition by antibody and cytotoxic T cells of a cloned murine leukemia cell line.Immunogenetics. 1981;12(1-2):101-15. doi: 10.1007/BF01561654. Immunogenetics. 1981. PMID: 6162788
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources